AnaptysBio's total assets for Q2 2025 were $335.25M, a decrease of -20.57% from the previous quarter. ANAB total liabilities were $379.98M for the fiscal quarter, a -2.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.